Precision Medicine is revolutionising childhood cancer treatment, offering tailored treatments based on a patient's unique genetic makeup and the specific characteristics of their cancer. This approach holds great promise for improving outcomes in childhood cancer, but what do families really think about it? Our recent paper published in the British Journal of Cancer titled, "Hopes, Concerns, Satisfaction, and Regret in a Precision Medicine Trial for Childhood Cancer: A Mixed-Methods Study of Parent and Patient Perspectives," delves into the experiences of families participating in precision medicine trials for childhood cancer, seeking to understand the complex impacts such trials can have. Importantly, we found that even when trial outcomes did not match their hopes, parents and patients rarely regretted their participation in the trial.
We recently wrote a blog post about this paper for Springer Nature, check it out and read the full post on their website here.
We recently wrote a blog post about this paper for Springer Nature, check it out and read the full post on their website here.
RSS Feed